Helmholtz Institute for Pharmaceutical Research Saarland (HIPS),
Helmholtz Centre for Infection Research (HZI),
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI)
Biogenic Nanotherapeutics group (BION)
Maximilian Richter studied pharmacy at Heidelberg University and finished his studies in 2016. He joined the Biogenic Nanotherapeutics group as a PhD student in 2017. His work is funded by Studienstiftung des Deutschen Volkes through a PhD fellowship.
In is studies he focuses on the evaluation and engineering of extracellular vesicles from mammals and bacteria for future clinical application. He is especially interested in using targeted extracellular vesicles to treat infectious diseases.